CMPX vs SPCE · $367.4M cap vs rev $7.0M
Compass Therapeutics Inc. (CMPX) versus Virgin Galactic Holdings Inc (SPCE) — a side-by-side from cached financials, not a winner call.
Compass Therapeutics Inc. (CMPX) is a biotechnology company listed on US.
Virgin Galactic Holdings Inc (SPCE) is a aerospace & defense company listed on NYSE.
CMPX does not have a complete income-statement cache yet.
Latest reported SPCE revenue for 2024-12-31 was $7.0M. Net income was -$346.7M. Revenue was up 3.5% from 2023-12-31 to 2024-12-31. SPCE currently screens at market cap $388.0M.
CMPX currently screens at market cap $367.4M. SPCE currently screens at market cap $388.0M.
Not investment advice. Open the CMPX and SPCE stock pages for the full models.
Not investment advice.